FemTech & Pregnancy Apps

Diabetes UK has partnered with the Department of Health & Social Care to educate the public on links between cardiovascular disease and diabetes, and how to reduce risks. …

ONE in four adults with Type 2 diabetes experience clinically significant hearing loss, a new systematic review and meta-analysis has found.1  This was particularly apparent in younger adults and resource-limited populations.  Diabetes and…

Cardiac arrest rhythm recognition improved significantly among newly hired emergency medical service (EMS) providers, with team-based learning and individual learning producing equivalent short-term gains in a randomised trial.   The…

MEN living with HIV are significantly more likely to experience premature ejaculation (PE) and depressive symptoms than HIV-negative individuals, according to findings from a multicentre case–control study. The…

MYELODYSPLASTIC syndromes may be more accurately stratified using a molecular evolution framework that integrates genomic trajectories with clinical data, improving prediction of both leukaemia free survival…

BALANCED fluid did not reduce major adverse kidney events compared with saline in children treated for septic shock. A large pragmatic clinical trial found no…

THE ALZHEIMER’S Association announced at AAIC 2026 the launch of PROTECT-Cog, a new global trial testing whether combining lifestyle interventions with a GLP-1 or similar…

Merck has announced FDA approval for enlicitide, the first FDA-approved once-daily oral pill designed to lower low-density lipoprotein cholesterol (LDL-C) in adults with hypercholesterolemia, including…

The European Medical Journal (EMJ) has been shortlisted for the Marketing Week Awards 2026.  EMJ has been named a finalist in the Excellence in Health…

Image: Juno Bio Juno Bio, a women’s health company focused on precision vaginal microbiome testing and multi-omics, has opened a sequencing lab built entirely for…